Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin + Perindopril FDC in Hypertension and Dyslipidemia
NCT04591808Phase 3Terminated
- Sponsor
- Servier
- Start
- Sep 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of atorvastatin, perindopril in hypertension (HTN), dyslipidemia, sponsored by Servier. Started Sep 2021; status: terminated.
02
Drugs
atorvastatinperindopril
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT04591808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591808.